Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study
Michelle Jacobs; Pamela S. Sherry; Leigh M. Taylor; Mary Amato; Gary R. Tataronis; Gary Cushing
J Am Pharm Assoc (2003) 2012;52:613-621. doi:10.1331/JAPhA.2012.10183


Objectives  To demonstrate that pharmacists working with physicians and other providers in an ambulatory care setting can improve glucose, blood pressure, and lipid control for patients with type 2 diabetes and to report patient adherence to screening and general preventive measures.

Design  Prospective, randomized, clinical practice study.

Setting  Burlington, MA, between January 2001 and August 2003.

Patients  164 patients patients with type 2 diabetes older than 18 years with glycosylated hemoglobin (A1C) greater than 8%.

Intervention  Pharmacist–patient clinic visits included obtaining a comprehensive medication review; performing targeted physical assessment; ordering laboratory tests; reviewing, modifying, and monitoring patients’ medication therapy and providing detailed counseling on all therapies; facilitating self-monitoring of blood glucose; and providing reinforcement of dietary guidelines and exercise.

Main outcome measure  Effect of clinical pharmacists working with physicians in an ambulatory setting on health measures (e.g., A1C, blood pressure, cholesterol) of patients with diabetes.

Results  Baseline characteristics were similar between the two groups. After 1 year, significant improvements occurred for A1C and low-density lipoprotein (LDL) cholesterol in the intervention group compared with the control group (A1C, 7.7% vs. 8.4%; LDL, 93.7 vs. 105.1 mg/dL; P < 0.05). Systolic blood pressure improved for all study patients without a difference between the two groups. Diastolic blood pressure improved significantly in the intervention group compared with the control group (73.4 mm Hg vs. 77.6 mm Hg, P < 0.05). Significantly more intervention patients were screened for retinopathy, neuropathy, and microalbuminuria than control patients ( P < 0.05).

Conclusion  For all indices measured, this study demonstrated that collaborative diabetes management with a clinical pharmacist can improve overall care.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.


Register for a FREE limited account to benefit from personalization features such as alerts.


Centers for Disease Control and Prevention.  National diabetes fact sheet, 2011. Accessed at www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf,  February 13, 2011.
The Diabetes Control and Complications Trial Research Group.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.  N Engl J Med.  1993; 329: 977– 86. [PubMed]
Nathan DM, Cleary PA, Backlund JY, et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.  N Engl J Med.  2005; 353: 2643– 53. [PubMed]
UK Prospective Diabetes Study (UKPDS) Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes.  Lancet.  1998; 352: 837– 53. [PubMed]
Action to Control Cardiovascular Risk in Diabetes Study Group.  Effects of intensive glucose lowering in type 2 diabetes.  N Engl J Med.  2008; 358: 2545– 59. [PubMed]
ADVANCE Collaborative Group.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.  N Engl J Med.  2008; 358: 2560– 72. [PubMed]
Duckworth W, Abraira C, Moritz T, et al.  Intensive glucose control and complications in American veterans with type 2 diabetes.  N Engl J Med.  2009; 360: 129– 39. [PubMed]
American Diabetes Association.  Standards of medical care in diabetes–2011.  Diabetes Care.  2011; 34( suppl. 1): S11– 61. [PubMed]
Saaddine JB, Cadwell B, Gregg EW, et al.  Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002.  Ann Intern Med.  2006; 144: 465– 74. [PubMed]
Chiquette E, Amato MG, Bussey HI.  Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.  Arch Intern Med.  1998; 158: 1641– 7. [PubMed]
Bluml BM, McKenney JM, Cziraky MJ.  Pharmaceutical care services and results in Project ImPACT: Hyperlipidemia.  J Am Pharm Assoc.  2000; 40: 157– 65.
Rupp MT, McCallian DJ, Sheth KK.  Developing and marketing a community pharmacy-based asthma management program.  J Am Pharm Assoc.  1997; NS37: 694– 9.
Hitchcock AM, Lousberg TR, Merenich J.  The impact of clinical pharmacy management on cardiovascular risk reduction in patients with established heart disease in a group model health maintenance organization [abstract 135].  Phamacotherapy.  2000; 20: 360– 1.
Gattis WA, Hasselblad V, Whellan DJ, et al.  Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team.  Arch Intern Med.  1999; 159: 1939– 45. [PubMed]
Gong C, Hasson NK, Lum BL.  Impact of a diabetes disease management clinic on the total glycosylated hemoglobin of patients with type 2 diabetes mellitus.  J Manag Care Pharm.  1999; 5: 511– 5.
Irons BK, Lenz RJ, Anderson SL, et al.  A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic.  Pharmacotherapy.  2002; 22: 1294– 330. [PubMed]
Coast-Senior EA, Kroner BA, Kelley CL, et al.  Management of patients with type 2 diabetes by pharmacists in primary care clinics.  Ann Pharmacother.  1998; 32: 636– 41. [PubMed]
Odegard PS, Goo A, Hummel J, et al.  Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention.  Ann Pharmacother.  2005; 39: 433– 40. [PubMed]
Nowak SN, Singh R, Clarke A, et al.  Metabolic control and adherence to American Diabetes Association practice guidelines in a pharmacist-managed diabetes clinic.  Diabetes Care.  2002; 25: 1479. [PubMed]
Clifford RM, Davis WA, Batty KT, et al.  Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.  Diabetes Care.  2005; 28: 771– 6. [PubMed]
Kelly C, Rodgers PT.  Implementation and evaluation of a pharmacist-managed diabetes service.  J Manag Care Pharm.  2000; 6: 488– 93.
Cranor CW, Christensen DB.  The Asheville Project: short term outcomes of a community pharmacy diabetes care program.  J Am Pharm Assoc.  2003; 43: 149– 59.
Jaber LA, Halapy H, Fernet M, et al.  Evaluation of a pharmaceutical care model on diabetes management.  Ann Pharmacother.  1996; 30: 238– 43. [PubMed]
Nau DP, Ponte CD.  Effects of a community pharmacist-based diabetes patient-managed program on intermediate clinical outcome measures.  J Manag Care Pharm.  2001; 8: 48– 53.
Letassy NA, Armor BL, Britton M, Farmer K.  Pharmacist-managed diabetes service in a family medicine practice improves patient outcomes.  Diabetes Trends.  2003; suppl: 21– 32.
Rothman R, Malone R, Bryant B.  Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes.  Am J Med Qual.  2003; 18: 51– 8. [PubMed]
Ragucci KR, Fermo JD, Wessell AM, et al.  Effectiveness of pharmacist-administered diabetes mellitus education and management services.  Pharmacotherapy.  2005; 25: 1809– 16. [PubMed]
McCord AD.  Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service.  Pharmacotherapy.  2006; 26: 248– 53. [PubMed]
Shane-McWhorter L, Oderda GM.  Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center.  Pharmacotherapy.  2005; 25: 96– 109. [PubMed]
Davidson MB, Karlan V, Hair TL.  Effect of a pharmacist-managed diabetes care program in a free medical clinic.  Am J Med Qual.  2000; 15: 137– 42. [PubMed]
Hogue VW, Babamoto KS, Jackson TB, et al.  Pooled results of community pharmacy-based diabetes education programs in underserved communities.  Diabetes Spectrum.  2003; 16: 129– 33.
Leal S, Herrier RN, Glover JJ, et al.  Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program.  Diabetes Care.  2004; 27: 2983– 4. [PubMed]
Cioffi ST, Caron MF, Kalus JS, et al.  Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic.  Ann Pharmacother.  2004; 38: 771– 5. [PubMed]
Morello CM, Zadvorny EB, Cording MA, et al.  Development and clinical outcomes of pharmacist-managed diabetes care clinics.  Am J Health Syst Pharm.  2006; 63: 1325– 31. [PubMed]
Kiel PJ, McCord AD.  Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice.  Ann Pharmacother.  2005; 39: 1828– 32. [PubMed]
Jameson JP, Baty PJ.  Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial.  Am J Manag Care.  2010; 16: 250– 5. [PubMed]
Choe HM, Mitrovich S, Dubay D, et al.  Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial.  Am J Manag Care.  2005; 11: 253– 60. [PubMed]
Johnson CL, Nicholas A, Divine H, et al.  Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service.  J Am Pharm Assoc.  2008; 48: 722– 30.
Iyer R, Coderre P, McKelvey T, et al.  An employer-based, pharmacist intervention model for patients with type 2 diabetes.  Am J Health Syst Pharm.  2010; 67: 312– 5. [PubMed]
Heart Protection Study Collaborative Group.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.  Lancet 2002; 360: 7– 22. [PubMed]
Wubben DP, Vivian EM.  Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review.  Pharmacotherapy.  2008; 28: 421– 36. [PubMed]
Rothman RL, Malone R, Bryant B, et al.  A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes.  Am J Med.  2005; 118: 276– 84. [PubMed]
Scott DM, Boyd ST, Stephan M, et al.  Outcomes of pharmacist-managed diabetes care services in a community health center.  Am J Health Syst Pharm.  2006; 63: 2116– 22. [PubMed]
Shojania KG, Ranji SR, McDonald KM, et al.  Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis.  JAMA.  2006; 296: 427– 40. [PubMed]
Isetts BJ, Brown LM, Schondelmayer SW, et al.  Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals.  Arch Intern Med.  2003; 163: 1813– 20. [PubMed]
Hammond RW, Schwartz AH, Campbell MJ, et al.  Collaborative drug therapy management by pharmacists.  Pharmacotherapy.  2003; 23: 1210– 25. [PubMed]
National Committee for Quality Assurance.  The state of health care quality: 2004. Accessed at www.ncqa.org/Portals/0/Publications/Resource%20Library/SOHC/SOHC_2004.pdf,  May 1, 2009.
National Committee for Quality Assurance.  The state of health care quality: 2010. Accessed at www.ncqa.org/Portals/0/State%20of%20Health%20Care/2010/SOHC%202010%20-%20Full2.pdf,  February 15, 2011.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints